Why early participant engagement is now a top priority in genetic disease research
pharmaphorum
JANUARY 18, 2023
The DNA of these so-called ‘genetic superheroes’ may contain clues about how to treat severe disease. Whether these people were truly naturally resistant to severe disease, and why that might be the case, remains a mystery. A decidedly contentious area in genomics is the patient’s ‘right not to know’.
Let's personalize your content